Pharm: AEDs Flashcards
voltage gated Na channel blockers
-zepine
promote inactivated state to limit sustained, repetitive firing of neurons
Tx: partial and secondarily generalized tonic-clonic seizures
GABA enhancers
pre- or postsynaptic enhancement of GABA synaptic inhibition
Tx: partial and secondarily generalized tonic-clonic seizures
voltage gated Ca channel blockers
inhibition of T-type Ca currents
Tx: absence seizure
carbamazepine
Na channel blocker
induces its own metabolism
AE: aplastic anemia; constipation/dry mouth
BBW: AGRANULOCYTOSIS
TERATOGEN: FETAL HYDANTOIN syndrome, SPINA BIFIDA
Tx: partial, including secondarily generalize seizures
clonazepam
GABA agonist
NO skin AE
ethosuximide
Ca channel blocker
Tx: absence seizure
felbamate
NMDA antagonist, GABA agonist
BBW: APLASTIC ANEMIA,bone marrow suppression, HEPATIC
gabapentin
inhibit alpha-2 delta-1 subunit of Ca channel
enhancement of presynaptic GABA release
lacosamide
PO, IV
Na channel blocker
NO skin AE
lamotrigine
Na channel blocker
BBW: SKIN (TEN/SJS)
TERATOGEN: inhibits dihydrofolate reductase; cleft
Tx: partial, including secondarily generalize seizures; primary generalized tonic-conic seizures; atypical absence, myoclonic, atonic seizures
levetiracetam
PO, IV
MoA: unknown
Tx: partial, including secondarily generalized seizures; primary generalized tonic-clonic seizures; atypical absence, myoclonic, atonic seizures
oxcarbazepine
Na channel blocker
possibly: increase K and decrease Ca effects
Tx: partial, including secondarily generalize seizures
phenytoin
PO, IV
Na channel blocker
PROTEIN BINDING
CYP induction: lots of drug interactions
highly variable metabolism
elimination: stool; ZERO order (T1/2 varies with dose)
AE: GINGIVAL HYPERPLASIA; HYPERTRICHOSIS; BLOOD DYSCRASIA
TERATOGEN: FETAL HYDANTOIN syndrome, cardiac, cleft, growth deficiency
pregabalin
inhibit alpha-2 delta-1 subunit of Ca channel
topiramate
Na channel blocker
decrease glutamate activity
increase K current and GABA
carbonic anhydrase inhibitor: renal bicarb loss
AE: renal stones
TERATOGEN: cleft lip/palate
valproate
PO, IV
Na channel blocker
inhibit GABA metabolism
(Ca channel blocker)
binds protein
AE: THROMBOCYTOPENIA, PROLONGED BLEEDING; HEPATIC, nausea, diarrhea
TERATOGEN: greatest risk; NEURAL TUBE, cleft, skeletal, developmental
Tx: primary generalized tonic-clonic seizures; absence seizures; atypical absence, myoclonic, atonic seizures
zonisamide
Na/Ca channel blocker
accumulates in RBCs
carbonic anhydrase inhibitor: renal bicarb loss
AE: renal stones
benzodiazepines
postsynaptic
GABA(A) receptor agonist: enhances Cl- influx
increase FREQUENCY (shift dose-response curve)
AE: dependence, withdrawal, sedation, tolerance
can give RAPID IV for seizure
barbiturates
postsynaptic
GABA(A) receptor agonist: enhances Cl- influx
increase DURATION
AE: dependence, withdrawal, sedation, tolerance
can give RAPID IV for seizure
AED’s in general
oral (slow release available)
limited protein binding
long T1/2
CYPs and UGT
hepatic metabolism
elimination: urine
AE: suicidal ideation, CNS effects, RASH (SJS/DRESS/TEN)
renal dysfunction can cause drug accumulation
need to routine monitoring: if levels high, ok if no AE
TAPER: prevent status epilepticus
fosphenytoin
phenytoin pro-drug
HLA-B 1502
Asians
increase chance of Steven Johnson’s and toxic epidermal necrolysis
CARBAMAZEPINE
also avoid: (fos)phenytoin, lamotrigine, oxcarbazepine
phenobarbital
CYP induction
teratogen: cleft, cardiac, urinary tract
Type of teratogenicity
- valproate
- phenytoin
- carbamazepine
- phenobarbital
- lamotrigine
- topirmate
- neural tube, cleft, skeletal, developmental delay
- FHS, cardiac, cleft
- FHS, spina bifida
- cleft, cardiac, urinary tract
- low folate; cleft
- cleft lip/palate